We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03428217
Brief Title: CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma (CANTATA)

First Submitted : February 5, 2018
First Submitted that Met QC Criteria : February 5, 2018
First Posted : February 9, 2018

Certification/Extension First Submitted : August 16, 2021
Certification/Extension First Submitted that Met QC Criteria : August 16, 2021
Certification/Extension First Posted : August 19, 2021

Last Update Submitted that Met QC Criteria : August 18, 2021
Last Update Posted : August 23, 2021